Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Duchenne muscular dystrophy
Biotech
Capricor shares more data for DMD therapy after initiating BLA
Capricor is now testing deramiocel in a phase 3 trial, HOPE-3, which plans to enroll up to 102 patients and is set to wrap up in Dec. 2026.
Darren Incorvaia
Oct 11, 2024 11:50am
Young participant in Pfizer's DMD gene therapy trial dies
May 7, 2024 4:29pm
Sarepta's next DMD drug seems to get the job done in phase 2
Jan 29, 2024 10:49am
Pfizer’s DMD gene therapy now ‘main game in town,' CSO says
Oct 31, 2023 2:28pm
FDA questions benefits, risks of Sarepta DMD gene therapy
May 10, 2023 11:02am
In a U-turn, FDA orders AdComm for Sarepta's DMD gene therapy
Mar 17, 2023 6:29am
